Diagnosis of X-linked lymphoproliferative disease by analysis of SLAM-associated protein expression

European Journal of Immunology

Volumn 30, Issue 6, 2000, Pages 1691-1697

  Gilmour, Kimberly C ^a,b,c   Cranston, Treena ^a,b,c   Jones, Alison ^a,b,c   Graham Davies, E ^a,b,c   Goldblatt, David ^a,b,c   Thrasher, Adrian ^a,b,c   Kinnon, Christine ^a,b,c   Nichols, Kim E ^a,b,c   Caspar, Hubert B ^a,b,c  

^a Great Ormond Street Hospital NHS Trust ^*  (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Common variable immunodeficiency; Protein expression; SLAM associated protein; X linked lymphoproliferative disease

Indexed keywords

ARTICLE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; LYMPHOPROLIFERATIVE DISEASE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPSIS; X CHROMOSOME LINKAGE;

AGAMMAGLOBULINEMIA; BASE SEQUENCE; CARRIER PROTEINS; CELL LINEAGE; CHILD; DYSKERATOSIS CONGENITA; FEMALE; GENE EXPRESSION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKOCYTES, MONONUCLEAR; LYMPHOPROLIFERATIVE DISORDERS; MALE; MOLECULAR SEQUENCE DATA; SEVERE COMBINED IMMUNODEFICIENCY; WISKOTT-ALDRICH SYNDROME; X CHROMOSOME;

EID: 0034076899     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200006)30:6<1691::AID-IMMU1691>3.0.CO;2-K     Document Type: Article

References (20)

1. Purtilo, D. T., Cassel, C. K., Yang, J. P. and Harper, R., X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet 1975. 1: 935-940.
2. Seemayer, T. A., Gross, T. G., Egeler, R. M., Pirruccello, S. J., Davis, J. R., Kelly, C. M., Okano, M., Lanyi, A. and Sumegi, J., X-linked lymphoproliferative disease: twenty-five years after the discovery. Pediatr. Res. 1995.38:471-478.
3. Grierson, H. L., Skare, J., Hawk, J., Pauza, M. and Purtilo, D. T., Immunoglobulin class and subclass deficiencies prior to Epstein-Barr virus infection in males with X-linked lymphoproliferative disease. Am. J. Med. Genet. 1991. 40: 294-297.
4. Brandau, O., Schuster, V., Weiss, M., Hellebrand, H., Fink, F. M., Kreczy, A., Friedrich, W., Strahm, B., Niemeyer, C., Belohradsky, B. H. and Meindl, A., Epstein-barr virus-negative boys with non-hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP). Hum. Mol. Genet. 1999. 8: 2407-2413.
5. Coffey, A. J., Brooksbank, R. A., Brandau, O., Oohashi, T., Howell, G. R., Bye, J. M., Cahn, A. P., Durham, J., Heath, P., Wray, P., Pavitt, R., Wilkinson, J., Leversha, M., Huckle, E., Shaw-Smith, C. J., Dunham, A., Rhodes, S., Schuster, V., Porta, G., Yin, L., Serafini, P., Sylla, B., Zollo, M., Franco, B. and Bentley, D. R., Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat. Genet. 1998. 20:129-135.
6. Nichols, K. E., Harkin, D. P., Levitz, S., Krainer, M., Kolquist, K. A., Genovese, C., Bernard, A., Ferguson, M., Zuo, L., Snyder, E., Buckler, A. J., Wise, C., Ashley, J., Lovett, M., Valentine, M. B., Look, A. T., Gerald, W., Housman, D. E. and Haber, D. A., Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc. Natl. Acad. Sci. USA 1998.95:13765-13770.
7. Sayos, J., Wu, C., Morra, M., Wang, N., Zhang, X., Allen, D., van Schaik, S., Notarangelo, L., Gêna, R., Roncarolo, M. G., Oettgen, H., De Vries, J. E., Aversa, G. and Terhorst, C., The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 1998. 395: 462-469.
8. Tangye, S. G., Lazetic, S., Woollatt, E., Sutherland, G. R., Lanier, L. L. and Phillips, J. H., Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. J. Immunol. 1999. 162: 6981-6985.
9. Yin, L., Ferrand, V., Lavoue, M. F., Hayoz, D., Philippe, N., Souillet, G., Seri, M., Giacchino, R., Castagnola, E., Hodgson, S., Sylla, B. S. and Romeo, G., SH2D1A mutation analysis for diagnosis of XLP in typical and atypical patients. Hum. Genet. 1999.105:501-505.
10. Caspar, H. B., Lester, T., Levinsky, R. J. and Kinnon, C., Bruton's tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): the use of protein analysis as a diagnostic indicator of XLA. Clin. Exp. Immunol. 1998.111: 334-338.
11. MacCarthy-Morrogh, L., Caspar, H. B., Wang, Y. C., Katz, F., Thompson, L., Layton, M., Jones, A. M. and Kinnon, C., Absence of expression of the Wiskott-Aldrich syndrome protein in peripheral blood cells of Wiskott-Aldrich syndrome patients. Clin. Immunol. Immunopathol. 1998. 88: 22-27.
12. Gross, T. G., Filipovich, A. H., Conley, M. E., Pracher, E., Schmiegelow, K., Verdirame, J. D., Vowels, M., Williams, L. L. and Seemayer, T. A., Cure of X-linked lymphoproliferative disease (XLP) with allogeneic hematopoietic stem cell transplantation (HSCT): report from the XLP registry. Bone Marrow Transplant. 1996.17:741-744.
13. Hoffmann, T., Heilmann, C., Madsen, H. O., Vindelov, L. and Schmiegelow, K., Matched unrelated allogeneic bone marrow transplantation for recurrent malignant lymphoma in a patient with X-linked lymphoproliferative disease (XLP). Bone Marrow Transplant. 1998. 22: 603-604.
14. Sylla, B. S., Wang, Q., Hayoz, D., Lathrop, G. M. and Lenoir, G. M., Multipoint linkage mapping of the Xq25-q26 region in a family affected by the X-linked lymphoproliferative syndrome. Clin. Genet. 1989. 36: 459-462.
15. Skare, J., Wu, B. L, Madan, S., Pulijaal, V., Purtilo, D., Haber, D., Nelson, D., Sylla, B., Grierson, H. and Nitowsky, H., Characterization of three overlapping deletions causing X-linked lymphoproliferative disease. Cenomics 1993.16: 254-255.
16. Futatani, T., Miyawaki, T., Tsukada, S., Hashimoto, S., Kunikata, T., Arai, S., Kurimoto, M., Niida, Y., Matsuoka, H., Sakiyama, Y., Iwata, T., Tsuchiya, S., Tatsuzawa, O., Yoshizaki, K. and Kishimoto, T., Deficient expression of Bruton's tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection. Blood 1998. 91: 595-602.
17. Frischmeyer, P. A. and Dietz, H. C., Nonsense-mediated mRNA decay in health and disease. Hum. Mol. Genet. 1999. 8: 1893-1900.
18. Arkwright, P. D., Makin, G., Will, A. M., Ayres, M., Gokhaie, D. A., Fergusson, W. D. and Taylor, G. M., X linked lymphoproliferative disease in a United Kingdom family. Arch. Dis. Child 1998. 79: 52-55.
19. Castro, A. G., Hauser, T. M., Cocks, B. G., Abrams, J., Zurawski, S., Churakova, T., Zonin, F., Robinson, D., Tangye, S. G., Aversa, G., Nichols, K. E., De Vries, J. E., Lanier, L.L. and O'Garra, A., Molecular and functional characterization of mouse signaling lymphocytic activation molecule (SLAM): differential expression and responsiveness in Th1 and Th2 cells. J. Immunol. 1999.163:5860-5870.
20. Mountford, R., PCR techniques for deletion, linkage and mutation analysis in Duchenne/Becker Muscular dystrophy. In Elles, R. (Ed.) Molecular Diagnosis of Genetic Disease. Humana Press, Totowa 1996, pp 17-36.